506414 — Fermenta Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹7.68bn
- IN₹8.08bn
- IN₹4.69bn
- 88
- 51
- 56
- 76
Annual cashflow statement for Fermenta Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 516 | 269 | -519 | -98.7 | 832 |
| Depreciation | |||||
| Non-Cash Items | 193 | 176 | 919 | 568 | 187 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -280 | -267 | 484 | 337 | -853 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 632 | 434 | 1,167 | 1,053 | 409 |
| Capital Expenditures | -553 | -371 | -405 | -192 | -221 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 137 | 111 | -158 | 37.1 | 220 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -415 | -260 | -563 | -155 | -1.59 |
| Financing Cash Flow Items | -175 | -167 | -205 | -167 | -124 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -11.4 | -216 | -408 | -909 | -509 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 205 | -41.7 | 196 | -10 | -101 |